Post COVID availability of oncology drugs - Is this the new normal on both sides of the Atlantic?

Autor: Parkes J; Worcestershire Oncology Centre, Worcestershire Acute Hospitals NHS Trust, Worcester, UK.; British Oncology Pharmacy Association, UK.; Immuno-Oncology Clinical Network, UK., Dodhia V; British Oncology Pharmacy Association, UK.; Mount Vernon Cancer Centre, East and North Hertfordshire Trust, Northwood, UK.; Aseptic Services, NHS England East of England, UK., Ziter S; National Community Oncology Dispensing Association, New York, USA., Olson N; National Community Oncology Dispensing Association, New York, USA., Ghose A; Immuno-Oncology Clinical Network, UK.; Mount Vernon Cancer Centre, East and North Hertfordshire Trust, Northwood, UK.; National Community Oncology Dispensing Association, New York, USA.; Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Medical Oncology, Medway NHS Foundation Trust, Gillingham, UK.; United Kingdom and Ireland Global Cancer Network, UK., Cracknell ANV; British Oncology Pharmacy Association, UK.; Ramsay Health Care, London, UK.; International Society of Oncology Pharmacy Practitioners, North Vancouver, BC, Canada., Wendy Ng HW; British Oncology Pharmacy Association, UK.; Mount Vernon Cancer Centre, East and North Hertfordshire Trust, Northwood, UK.
Jazyk: angličtina
Zdroj: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Dec; Vol. 29 (8), pp. 2045-2048. Date of Electronic Publication: 2023 Sep 20.
DOI: 10.1177/10781552231202212
Abstrakt: Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Databáze: MEDLINE